Using continuous glucose monitors to improve diabetes testing for older adults
Part of Hormones & metabolism clinical trials.
This study tests a new way to diagnose diabetes in older adults by using a continuous glucose monitor (CGM) — a small sensor worn on the arm — to get a more accurate picture of blood sugar than the standard A1c test alone. If you qualify, you'll wear the sensor for about 48 days, and the results may help your doctor know whether you truly have diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 65 years of age or older.
- Your A1c (average blood sugar) must be between 5.3% and 7.4%, but you must not have been diagnosed with diabetes or taken diabetes medication.
- Your recent blood tests must suggest that your A1c might not tell the full story — you need to meet one of two specific patterns the researchers look for.
- You must have had at least five A1c tests and three complete blood count (CBC) tests in your medical records over the past 10 years.
- You must agree to wear a small continuous glucose monitor (CGM) sensor on your arm for up to 48 days.
- You must let the researchers use your medical records and agree to share records from other health care facilities.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether using a continuous glucose monitor (CGM, a sensor that tracks blood sugar) is practical and helpful for people with type 2 diabetes in primary care settings. It focuses on people who may have a harder time getting diabetes support and have higher A1c levels.
This study checks how well periodic continuous glucose monitoring works for adults with type 2 diabetes. You may be asked to wear a sensor that tracks glucose more often than finger-stick checks, which can help improve day-to-day glucose control.
This study compares two ways of tracking blood sugar in people with type 2 diabetes who use insulin. It aims to see if one method helps manage glucose better, which could improve daily control and long-term health.
This real-world study tests whether using a continuous glucose monitor (isCGM) with or without pharmacist coaching helps people with type 2 diabetes who are not on insulin improve their blood sugar control. It compares these approaches to standard blood sugar checking and looks for better HbA1c results after three months.
This trial tests if using a continuous glucose monitor (CGM) helps older adults with type 2 diabetes who are not on insulin to better control their blood sugar. The results will show if CGM is a helpful tool for managing diabetes without daily shots.
This study tests whether using a continuous glucose monitor (CGM) helps people without diabetes improve their insulin sensitivity. You would wear a small sensor that tracks your glucose levels in real time, and the study may help you understand how your body responds to food and activity.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.